Breaking News Instant updates and real-time market news.

TARO

Taro Pharmaceutical

$100.31

-1.85 (-1.81%)

17:06
12/01/16
12/01
17:06
12/01/16
17:06

Taro Pharmaceutical names Abhay Gandhi interim CEO

Taro Pharmaceutical Industries announced that its board has appointed Abhay Gandhi to the position of interim CEO, effective January 1, 2017. As previously announced, the interim CEO will serve in this role during the period from Kal Sundaram's departure at the end of this year until the arrival in April 2017 of Uday Baldota, Taro's recently appointed CEO. Gandhi currently serves as the CEO of the Sun Pharmaceutical Industries North America operations, a position he succeeded from Sundaram. Taro's board has also nominated Mr. Gandhi to its board.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.